Overview

A Phase 1 Food Effect Study of TAK-536TCH Final Formulation Tablet

Status:
Completed
Trial end date:
2015-03-01
Target enrollment:
Participant gender:
Summary
This is a phase 1, randomized, open-label, crossover study to evaluate the food-effect of single oral dose of TAK-536TCH final formulation tablet in healthy adult male participants.
Phase:
Phase 1
Details
Lead Sponsor:
Takeda
Treatments:
Azilsartan medoxomil